ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FUM Futura Medical Plc

39.00
0.10 (0.26%)
Last Updated: 11:15:52
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 0.26% 39.00 38.80 39.25 39.10 38.85 39.05 136,534 11:15:52
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 3.1M -6.51M -0.0217 -17.97 117.28M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 38.90p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £117.28 million. Futura Medical has a price to earnings ratio (PE ratio) of -17.97.

Futura Medical Share Discussion Threads

Showing 12951 to 12969 of 21550 messages
Chat Pages: Latest  526  525  524  523  522  521  520  519  518  517  516  515  Older
DateSubjectAuthorDiscuss
08/8/2022
08:15
And according to the ASA, EU courts and FTC in the USA without an adequately controlled study it cannot be claimed to have an effect beyond a placebo



The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence,



What standards are applied to evidence? The position taken by the ASA is a tried and tested one which has developed over the course of many years. It reflects the opinion of the wider scientific and academic community, rather than judgements made solely by the ASA. There are many aspects that are taken into consideration when evidence is reviewed and each claim is judged on its merits alongside the evidence presented to support it. Evidence submitted for health claims should normally include at least one adequately controlled experimental human



In each of the six cases filed, FTC alleged that the companies not only lacked scientific substantiation for their claims regarding the health benefits of their CBD/CBG products, but also falsely represented that their claims were either scientifically proven or had been confirmed by the U.S. government.

Under the proposed orders settling FTC complaints in each of these cases, the companies and their owners are prohibited from making prevention, treatment, or safety claims similar to the ones the companies made about their products about any dietary supplements, foods, and drugs unless they have the human clinical testing to substantiate such claims, and are required to have competent and reliable scientific evidence for any other health-related product claims. Specifically, the testing must be: (1) randomized, double-blind, and placebo-controlled; and (2) conducted by researchers qualified by training and experience to conduct such testing. All of the companies must also notify consumers of the Commissions order, and all but one of the companies will also be required to pay monetary judgments

lbo
08/8/2022
07:47
More lies from Petroc the proven liar! The EU is not’ approving’ MED or that it even works. That is not what a CE Mark does



‘court did not concur with the defendant’s arguments. It stated that the CE conformity assessment is neither an official approval procedure nor an administrative legal act. The so-called “notified bodies” which carry out conformity checks and award the CE-certificates are private companies. The tests carried out by these companies therefore rather amount to plausibility checks, which, moreover, only concern individual aspects, for example, of a production process’

lbo
06/8/2022
02:54
"I've just bought more, I'm happy to say."

Hooray!

glavey
05/8/2022
16:38
Its all a ‘swindle’ by the rampers like Petroc using Muti-IDs





The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence,



What standards are applied to evidence? The position taken by the ASA is a tried and tested one which has developed over the course of many years. It reflects the opinion of the wider scientific and academic community, rather than judgements made solely by the ASA. There are many aspects that are taken into consideration when evidence is reviewed and each claim is judged on its merits alongside the evidence presented to support it. Evidence submitted for health claims should normally include at least one adequately controlled experimental human

lbo
05/8/2022
11:04
I've just bought more, I'm happy to say.
dontshoutatonce
05/8/2022
10:42
I see LiarBO freely admits that MED3000 is what he describes 'a clinically proven placebo treatment for ED'. He also informs us regularly (circa 5 times a day) that MED has not been tested against a placebo. What he doesn't point out is that just because it hasn't been tested against placebo, doesn't mean that it doesn't work in reality. In fact, all the testing so far has shown that MED3000 works very well indeed. So how am I 'a proven liar' for saying 'It works!'? It's a fact - it does work. Even the FDA believes in its efficacy, because the reason they wanted the 6 month trial was to ensure it maintained its efficacy over a longer period. What LiarBO has never done is presented the slightest shred of evidence to show that it doesn't work. So who's the proven liar?
petroc
04/8/2022
21:44
All Futura have done is allow Reckitt to sell lubricants/arousal gels as clinically proven placebo treatments for ED. And report Med3000 to the ASA, FTC etc for being misleading if it doesn't inform consumers that Med3000 itself has no proven effect in ED beyond a placebo. As it has not proven efficacy in any adequately placebo controlled study or even against any standard cooling lubricant/arousal gelhttps://amp.theguardian.com/business/shortcuts/2015/dec/14/how-bad-was-what-nurofen-did-austalian-courtsPlacebo-nomics: how bad was what Nurofen did?Australian courts have ordered the makers of the brand to stop repackaging identical painkillers for different pains where does marketing end and deception begin?Lies come in a wide range of ethical shapes and sizes. There are white ones, diplomatic ones, and there are mean, self-serving ones. Apparently there are even nice, Christmassy ones.The Australian federal court yesterday ordered the drug giant Reckitt Benckiser to stop selling identical products marketed as specific Nurofen varieties for back pain, period pain, migraine pain and tension headaches. The company admitted the drugs sold in different coloured packets all contained the same active ingredient: 342mg of ibuprofen lysine. It also sold them at almost twice the price of Nurofens standard ibuprofen products.Whether this constitutes deception or just marketing is probably one for the lawyers to argue over. Whatever its called, such practices might appear to fall pretty unequivocally towards the self-serving whopper end of the scale
lbo
04/8/2022
21:40
Petroc is a proven liar using Multi-IDs. He has posted false claims on ADVFN as ‘FACTS’. And never gave any disclaimers until challenged that they were not actually facts as he had tried to claim at the time.




petroc - 09 Jan 2022 - 16:44:16 - 10345 of 10423

Of course it works

petroc22 Jan '22 - 19:08 - 10569 of 10768

What is not to love Eroxon /MED3000 - HERE ARE THE FACTS



The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence,



What standards are applied to evidence? The position taken by the ASA is a tried and tested one which has developed over the course of many years. It reflects the opinion of the wider scientific and academic community, rather than judgements made solely by the ASA. There are many aspects that are taken into consideration when evidence is reviewed and each claim is judged on its merits alongside the evidence presented to support it. Evidence submitted for health claims should normally include at least one adequately controlled experimental human

lbo
04/8/2022
21:35
Where is the adequately controlled study to prove Med3000 is having any effect beyond a placebo? Not even FM71 is adequately controlled to claim any effect beyond placebo!



In each of the six cases filed, FTC alleged that the companies not only lacked scientific substantiation for their claims regarding the health benefits of their CBD/CBG products, but also falsely represented that their claims were either scientifically proven or had been confirmed by the U.S. government.

Under the proposed orders settling FTC complaints in each of these cases, the companies and their owners are prohibited from making prevention, treatment, or safety claims similar to the ones the companies made about their products about any dietary supplements, foods, and drugs unless they have the human clinical testing to substantiate such claims, and are required to have competent and reliable scientific evidence for any other health-related product claims. Specifically, the testing must be: (1) randomized, double-blind, and placebo-controlled; and (2) conducted by researchers qualified by training and experience to conduct such testing. All of the companies must also notify consumers of the Commissions order, and all but one of the companies will also be required to pay monetary judgments

lbo
04/8/2022
15:16
Petroc is a proven liar using Multi-IDs all over the internet to try pump Futura. He lied when he said the evaporative cooling effect of Dermasys could not be replicated. The ramping liars can try childish tactics to deflect but cannot filter the factspetroc - 20 Feb 2020 - 10:14:36PDT, as Dermasys has been Futura's core product for several years, and upon which they base their marketing strategy, I very much doubt that it's easy to replicate faithfully or legally. Besides, there are many "wonder creams" out there that claim to do the job,(a friend tells me), and yet research still continues for something that actually does.https://www.pharma-mkting.com/blog/no-goopy-ed-gel-in-gsks-futura/We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK saidhttps://www.gskhealthpartner.com/content/dam/cf-consumer-healthcare/health-professionals/en_IN/pdf/article-1.pdfThe cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.Voltaren vehicle gel application resulted in a rapid reduction of skin surface temperature by 5.1°C after only 3 minhttps://www.edisoninvestmentresearch.com/?ACT=18&ID=10479There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial product
lbo
04/8/2022
14:14
LiarBO, thank you for posting all the evidence that proves I'm not a ramper. In fact it proves that you are a stockbasher, as almost everything applies to you but in a negative way. Nothing there even suggests that I'm a ramper, merely a LTH who obviously wants his holding to do well. You'll have forgotten what that's like since you lost all your money on FUM. You'll have forgotten the excitement as the share price rises, all you live for now is to try and exact revenge because you were such a novice that you invested more than you could afford to lose, and then consolidated your loss by selling at the bottom of the market. Hahaha! What a sorry little loser you are! I expect Glavey is in the same boat as you, given that all his comments are 1. Pointless, 2. Pure invective towards LTHs. I suppose that at least he doesn't spend every minute of the day repeating himself in a desperate attempt to keep his posts at the top of the board like you, saddo.
petroc
04/8/2022
11:39
Back with your endless, pointless boring repetition eh LBO - it was so pleasant with you 'staying away' for some reason

perhaps you were away on a rubbing (your favourite pastime) holiday ?

mikethebike4
04/8/2022
10:45
Petroc is a proven ramping Liar. The share price did not get to 90p in December 2019 or in 2021 even with all his multi-ID ramping everywhere on the internet.



1. The rampers post exorbitant stock price predictions.
3. They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are "full of it."
4. You cannot have an intelligent discussion with these types. They will do whatever they can to discredit those who disagree with them by spreading false information. They are very often antagonistic.
5. They post their predictions over and over and over desperately hoping to move the market. They never do, because what they say is insignificant to the market.



petroc - 01 Dec 2019 - 11:12:08 - 6461 of 10529

I'm sticking to the prediction I made last week - 92p, mid December.

petroc - 27 Nov 2019 - 11:52:54 - 6439 of 10529

92p, mid December.

lbo
04/8/2022
09:13
You'd best take yourself off over there then Pet, where you can stimulate one another to your heart's content.
glavey
04/8/2022
08:47
If anyone wants to read some proper chat about FUM they should head over to the LSE board. ADVFN have allowed this cesspit of a bb to become a haven for anti-FUM propagandists and stock bashers. LSE had the wisdom to ban lbo when he was over there under the alias of LiamBooth, and Glavey is the king of the pointless comment, who only appears when the share price rises. BTW, don't go investing more than you can afford to lose in FUM - we've had false dawns before. LiarBO did exactly that when he thought that CSD500 was going to make him a fortune, but it failed to sell and he lost all his money, and the money he borrowed. Since then -five years ago!- he has spent all his time posting anti FUM propaganda out of spite.
petroc
04/8/2022
05:26
Open Short Positions in Futura Medical

There are currently no open short positions in Futura Medical.

glavey
03/8/2022
15:03
The silence has been deafening! LOL



In Q2 2022 national applications will need to be made and the Company, in consultation with its commercial partners, will decide those countries in which to file applications and considered necessary to protect the commercial interests of MED3000. If national applications are successful



Most third party challenges to patentability occur in front of national or regional patent offices. WIPO recently released a summary of data regarding the extent to which third parties are challenging patentability at the international level. Any member of the public can file Third Party Observations against a PCT application during the international phase.



There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial products

lbo
03/8/2022
14:18
LBO was the first in the queue

He's so clever !

mikethebike4
03/8/2022
14:00
Massive short squeeze continues


Very limited free float


Marketplace potential of over 200 million eager men

j777j
Chat Pages: Latest  526  525  524  523  522  521  520  519  518  517  516  515  Older

Your Recent History

Delayed Upgrade Clock